Pay in 4 interest-free payments of $5.29 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Loprinzi et al
Lixisenatide Monotherapy GetGoal-Mono was a 12-week, double-blind, placebo-controlled trial that randomised 361 patients with type 2 diabetes of mean duration 1.11.4 years attempting to control their diabetes with diet and exercise alone, to lixisenatide OD for 12 weeks as a one-step dose increase (10 g for 2 weeks, then 20 g) or two-step dose increase (10 g for 1 week, 15 g for 1 week, then 20 g), or placebo also with a one- or two-step increase [17]
It is used for liver disease
doi: 10.1016/j.endien.2023.12.001 43 RubinoDAbrahamssonNDaviesMHesseDGreenwayFLJensenCet al
US$ 23.35
:max_bytes(150000):strip_icc()/health-GettyImages-1498826563-72ccaac18ecf41e49988eccfc823270f.jpg)
US$ 26.90
US$ 25.15
US$ 28.04
US$ 20.74
US$ 21.39
:max_bytes(150000):strip_icc()/GettyImages-1299286851-18ab6e02931940ad963dda93851b6dc7.jpg)